Biomedical Research Unit
The National Institute for Health Research (NIHR)
The overall vision of the NIHR is to improve the health and wealth of the nation by creating a health research system in which the NHS supports outstanding individuals, working in world class facilities, conducting leading edge research focused on the needs of the patients and the public. The NIHR has established Biomedical Research Units to undertake translational clinical research in priority areas of high disease burden and clinical need to further enhance its abilities to deliver on this overall goal.
Our Research |
|
|
The benefits of Biomedical Research Unit funding shine through all elements of our research activities. The BRU is creating the infrastructure to allow us to conduct first in man, early phase and more applied translational studies across a whole range of cardiovascular themes. These include studies in children, stem cell and platelet functions research as well as specific imaging projects. Excitingly, our research is also integrated into a much wider research network within Bristol, ranging from newly created facilities (such as the Clinical Research and Imaging Centre) to a vibrant and ambitious Bristol–wide strategic research and innovation partnership for health (BRIG-H) that was co-founded by the University of Bristol and UHBristol.
For further information please visit: Bristol Clinical Trials and Evaluation Unit - The CTEU is the heart of the Bristol BRU and coordinates all research activities involving patients. UK Experimental Medicine Resource Finder - A unique resource providing information about experimental medicine in the UK, and providing an overview of facilities and research areas within the BRU. |
“The award of the NIHR BRU has created a state of the art facility inspiring collaboration between scientists and clinicians to translate new research insights into benefits for patients. We can now perform internationally competitive research and, at the same time, train the next generation of cardiovascular scientists and clinicians.”
Professor Gianni Angelini, |